Ziconotide Acetate Patent Expiration
Ziconotide Acetate is Used for managing severe chronic pain through intrathecal infusion in patients also receiving morphine. It was first introduced by Tersera Therapeutics Llc
Ziconotide Acetate Patents
Given below is the list of patents protecting Ziconotide Acetate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Prialt | US5364842 | Method of producing analgesia |
Dec 30, 2016
(Expired) | Tersera |
| Prialt | US5795864 | Stable omega conopetide formulations |
Jun 27, 2015
(Expired) | Tersera |
| Prialt | US8653033 | Method for administering omega-conopeptide | Oct 01, 2024 | Tersera |
| Prialt | US8765680 | Method for administering omega-conopeptide | Oct 01, 2024 | Tersera |
| Prialt | US9707270 | Method for administering ω-conopeptide | Oct 01, 2024 | Tersera |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳